HOLDEN LOWELL THOMAS (CFO) reported 1 transaction at NASCENT BIOTECH INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/9/2023ACC: 0001477932-23-008224
DirectorOfficer· CFO
+1.39M
Net shares
Net buyer
$173.3K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.39M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.39M
Price / share
$0.13
Trade value
$173.29K
% of position
16.7%
—
8.29M→9.68M
Total
Net shares
+1.39M
Net value
$173.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | J · J | +1.39M | $0.13 | $173.29K | 16.7% | 8.29M | 9.68M |
| Total | +1.39M | $173.29K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2M
Total
2M indirect2M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2M | Indirect |
| Total | 2M | 2M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported